Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease

被引:22
作者
Baiocchi, L. [1 ]
Angelico, M. [1 ]
Petrolati, A. [1 ]
Perrone, L. [2 ]
Palmieri, G. [3 ]
Battista, S. [3 ]
Carbone, M. [1 ]
Tariciotti, L. [2 ]
Longhi, C. [1 ]
Orlando, G. [2 ]
Tisone, G. [2 ]
机构
[1] Univ Roma Tor Vergata, Dept Internal Med, Hepatol Unit, Rome, Italy
[2] Univ Roma Tor Vergata, Chair Transplant Surg, Rome, Italy
[3] Univ Roma Tor Vergata, Dept Human Pathol, Rome, Italy
关键词
HCV; liver fibrosis; liver transplantation;
D O I
10.1111/j.1600-6143.2007.02107.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hepatitis C virus (HCV) re-infection after liver transplantation (LT) is characterized by an accelerated disease progression in recent years with unclear mechanisms. We evaluate the relationship between progression of liver fibrosis and histological necro-inflammation in HCV recipients, according to age of transplant. Fifty-five patients transplanted (1993-2002) for HCV liver disease, were included in the study. Recipients were retrospectively stratified in three different age of transplant, of 40 months each: group 1) from January 1993 to May 1996; group 2) from June 1996 to august 1999; group 3) from September 1999 to December 2002. Grading (necro-inflammation) and staging (fibrosis) scores were evaluated in liver biopsies at 1, 2 and 3 years from LT (Ishak classification). For all age of transplant the main factor associated with fibrosis progression, was grading score (p < 0.05). However mean staging score for each point of grading increased from 0.3 +/- 0.2 in older LT to 0.7 +/- 0.5 in newer ones (p = 0.01). In conclusion in HCV-LT patients (1) liver fibrosis is strictly associated to histological necro-inflammation; (2) the proportion of this relationship has been changing in recent years since newer LT patients, show an increased amount of fibrosis in comparison with the older ones, for similar grading score.
引用
收藏
页码:673 / 678
页数:6
相关论文
共 47 条
[1]   Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C [J].
Abdelmalek, MF ;
Firpi, RJ ;
Soldevila-Pico, C ;
Reed, AI ;
Hemming, AW ;
Liu, C ;
Crawford, JM ;
Davis, GL ;
Nelson, DR .
LIVER TRANSPLANTATION, 2004, 10 (02) :199-207
[2]   Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver [J].
Albrecht, JH ;
Poon, RYC ;
Ahonen, CL ;
Rieland, BM ;
Deng, CX ;
Crary, GS .
ONCOGENE, 1998, 16 (16) :2141-2150
[3]   Hepatic steatosis: A specific sign of hepatitis C reinfection after liver transplantation [J].
Baiocchi, L ;
Tisone, G ;
Palmieri, G ;
Rapicetta, M ;
Pisani, F ;
Orlando, G ;
Casciani, CU ;
Angelico, M .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (06) :441-447
[4]   A model to predict severe HCV-related disease following liver transplantation [J].
Berenguer, M ;
Crippin, J ;
Gish, R ;
Bass, N ;
Bostrom, A ;
Netto, G ;
Alonzo, J ;
Garcia-Kennedy, R ;
Rayón, JM ;
Wright, TL .
HEPATOLOGY, 2003, 38 (01) :34-41
[5]   Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation [J].
Berenguer, M ;
Prieto, M ;
Rayón, JM ;
Mora, J ;
Pastor, M ;
Ortiz, V ;
Carrasco, D ;
San Juan, F ;
Burgueño, MDJ ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2000, 32 (04) :852-858
[6]   What determines the natural history of recurrent hepatitis C after liver transplantation? [J].
Berenguer, M .
JOURNAL OF HEPATOLOGY, 2005, 42 (04) :448-456
[7]   Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients [J].
Berenguer, M ;
Prieto, M ;
San Juan, F ;
Rayón, JM ;
Martinez, F ;
Carrasco, D ;
Moya, A ;
Orbis, F ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2002, 36 (01) :202-210
[8]   HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].
Berenguer, M ;
Ferrell, L ;
Watson, J ;
Prieto, M ;
Kim, M ;
Rayón, M ;
Córdoba, J ;
Herola, A ;
Ascher, N ;
Mir, J ;
Berenguer, J ;
Wright, TL .
JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684
[9]   Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation:: association with treatment of rejection [J].
Berenguer, M ;
Prieto, M ;
Córdoba, J ;
Rayón, JM ;
Carrasco, D ;
Olaso, V ;
San-Juan, F ;
Gobernado, M ;
Mir, J ;
Berenguer, J .
JOURNAL OF HEPATOLOGY, 1998, 28 (05) :756-763
[10]   Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression [J].
Berenguer, M ;
Aguilera, V ;
Prieto, M ;
San Juan, F ;
Rayón, JM ;
Benlloch, S ;
Berenguer, J .
JOURNAL OF HEPATOLOGY, 2006, 44 (04) :717-722